Cargando…
Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
Background: Hospitalized COVID-19 patients with hypoxemic respiratory failure may deteriorate despite invasive mechanical ventilation and thus require extracorporeal membrane oxygenation (ECMO) support. Unfractionated heparin (UFH) is the antithrombotic of choice, however, bivalirudin may offer more...
Autores principales: | Diaz, Dayne, Martinez, Jenny, Bushman, Grant, Wolowich, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487306/ https://www.ncbi.nlm.nih.gov/pubmed/37682210 http://dx.doi.org/10.1051/ject/2023027 |
Ejemplares similares
-
Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022) -
Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support
por: Trigonis, Russell, et al.
Publicado: (2022) -
Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure
por: Seeliger, Benjamin, et al.
Publicado: (2021) -
Update on Anticoagulation Strategies in Patients with ECMO—A Narrative Review
por: Šoltés, Ján, et al.
Publicado: (2023) -
Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017)